Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists-Reference-Cited by-同舟云学术

Synthesis, enantioresolution, and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists

Published:2012-06 Issue:12 Volume:20 Page:3781-3792
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Cilibrizzi Agostino,Schepetkin Igor A.,Bartolucci Gianluca,Crocetti Letizia,Dal Piaz Vittorio,Giovannoni Maria Paola,Graziano Alessia,Kirpotina Liliya N.,Quinn Mark T.,Vergelli Claudia

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference47 articles.

1. Innate immunity: an overview

2. Synthesis and Biological Evaluation of N-Pyrazolyl-N‘-alkyl/benzyl/phenylureas: a New Class of Potent Inhibitors of Interleukin 8-Induced Neutrophil Chemotaxis

3. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution

4. Atherosclerosis: The New View

5. Resolution of in flammation: state of the art, definitions and terms

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The formyl peptide receptors FPR1 and FPR2 as targets for inflammatory disorders: recent advances in the development of small-molecule agonists;European Journal of Medicinal Chemistry;2024-02

2. Developmental and homeostatic signaling transmitted by the G-protein coupled receptor FPR2;International Immunopharmacology;2023-05

3. Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity;Molecules;2022-06-10

4. Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis;Molecules;2021-10-30

5. Developing selective FPR2 agonists can be a potential approach to treat moderate to severe asthma;2021-09-17